Mount Laurel, New Jersey – March 28, 2025 – United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company’s regulatory and capital markets activities. As previously disclosed, the FDA requested that certain additional sterilization and biocompatibility tests be included in the company’s Investigational Device Exemption (IDE) application. An IDE approval is a […]
Press Releases
United Health Products Provides Update on Capital Markets and Regulatory Processes
Mount Laurel, New Jersey – March 13, 2025 – United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company’s regulatory and capital markets activities. As previously disclosed, UHP has submitted an application to OTC Markets to have its common shares quoted on the OTCQB market, which the company believes will increase the […]
United Health Products Provides Update on FDA PMA Application Process
Mount Laurel, New Jersey – January 31, 2025 – United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company’s regulatory and capital markets activities. As previously disclosed, UHP submitted to the FDA an Investigational Device Exemption application (IDE) last November, the approval of which is a precondition to enroll patients in the […]
United Health Products Provides Update on Clinical Study Process
Mount Laurel, New Jersey – December 2, 2024 – United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company’s planned clinical study. As previously disclosed, United Health Products is conducting a clinical trial of its CelluSTAT Hemostatic Gauze product (formerly branded as HemoStyp) in response to the FDA’s request for additional clinical […]
United Health Products Provides Update on FDA PMA Application
Mount Laurel, New Jersey – November 4, 2024 – United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company’s FDA Premarket Approval (PMA) application process. Following the company’s August 15, 2024 submission of its Submission Issue Request (SIR) to the FDA which responded to certain questions in the FDA’s June 18 letter […]
United Health Products Submits Response Letter to FDA
Mount Laurel, New Jersey – August 19, 2024 – United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company’s FDA Premarket Approval (PMA) application process. Following the company’s March 21 submission of its PMA application and the FDA’s June 18 “Deficiencies Letter” to the company listing certain questions and comments on various […]